Kunz J, Gottschalk J, Jänisch W, Schulz W
Acta Histochem. 1986;80(1):53-61.
The results of histoautoradiographic and immunohistochemical studies of biopsy specimens of 15 brain tumours are reported. The specimens were labeled with 3H-thymidine using an in vitro technique. Meningiomas, oligodendrogliomas and well differentiated astrocytomas showed a median S-phase fraction of about 1%. In contrast, the labeling indices of 4 from 7 anaplastic astrocytomas were higher (2.1, 3.0, 3.5, 11.4). With increasing degree of malignancy the proliferative heterogeneity of the tumours increases. In every glioma varying amounts of glial fibrillary acidic protein (GFAP) were detected immunohistochemically (PAP technique). In 3 high-grade gliomas (2 glioblastomas, 1 anaplastic astrocytoma) an inverse relation of the investigated parameters (high S-phase fraction, low GFAP expression) was found. An exact prediction on biological behaviour of an individual tumour by GFAP detection immunohistochemically is not possible, because a high GFAP content can be detected also in some malignant tumours. However, the 3H-thymidine labeling indices of viable parts of the tumours, probably reflecting the growth fraction seem to be clinically important parameters, especially in respect to the prognosis.
本文报告了15例脑肿瘤活检标本的组织放射自显影和免疫组化研究结果。标本采用体外技术用³H-胸腺嘧啶核苷进行标记。脑膜瘤、少突胶质细胞瘤和高分化星形细胞瘤的S期分数中位数约为1%。相比之下,7例间变性星形细胞瘤中有4例的标记指数较高(2.1、3.0、3.5、11.4)。随着恶性程度的增加,肿瘤的增殖异质性增加。在每例胶质瘤中,通过免疫组化(PAP技术)检测到不同量的胶质纤维酸性蛋白(GFAP)。在3例高级别胶质瘤(2例胶质母细胞瘤、1例间变性星形细胞瘤)中,发现所研究参数(高S期分数、低GFAP表达)呈负相关。通过免疫组化检测GFAP不可能对单个肿瘤的生物学行为做出准确预测,因为在一些恶性肿瘤中也能检测到高GFAP含量。然而,肿瘤存活部分的³H-胸腺嘧啶核苷标记指数可能反映生长分数,似乎是重要的临床参数,尤其是在预后方面。